Clarifying SARS-CoV GoF work funding by the NIH/NIAID since 2014

As once again renewed discussion about sarscov2 origins re-emerges, the ecohealth coronavirus gain of function work had started in 2014! And was funded by BOTH the NIH(Collins)and niaid (Fauci) on 7/24/2019.

What now appears to be the point of argument is whether the work in the grant is considered to be a gain of function. To understand if it was a gain of function requires understanding of gene editing technologies. There are three types of cloning: gene cloning, reproductive cloning, and therapeutic cloning. Gene cloning is essentially recombinant DNA/RNA technology, where a piece of FOREIGN ( non bat 🦇) DNA/RNA is inserted into a vector, which can be copied by a host cell. This work “using clone technology” on sars-cov S protein to test %divergence threshold in S protein spillover effects in HUMAN population was defined and APPROVED in the grant that had started in 2014 and was funded in 2019. The NIH and NIAID were perfectly aware of this work since 2014. https://twitter.com/futurenews2020/status/1351803028131647489?s=21